Literature DB >> 2003709

Emboli in infective endocarditis: the prognostic value of echocardiography.

J M Steckelberg1, J G Murphy, D Ballard, K Bailey, A J Tajik, C P Taliercio, E R Giuliani, W R Wilson.   

Abstract

OBJECTIVE: To determine whether vegetations visualized on two-dimensional echocardiography are an independent risk factor for the development of subsequent emboli in patients with infective endocarditis and to assess the timing of emboli relative to the initiation of antimicrobial therapy.
DESIGN: Investigator-blinded, retrospective incidence cohort study.
SETTING: Tertiary referral center. PATIENTS: Patients with left-sided native valve infective endocarditis who had two-dimensional echocardiography within 72 hours of beginning antimicrobial therapy.
MEASUREMENTS AND MAIN RESULTS: The crude incidence rate of first embolic events in patients receiving antimicrobial therapy was 6.2 per 1000 patient-days (95% CI, 4.2 to 9.2). The rates in patients with and without vegetations were 7.1 and 4.9 per 1000 patient-days, respectively (incidence rate ratio, 1.4; 95% CI, 0.6 to 3.3). The relation between vegetations and risk for emboli was microorganism-dependent: Stratified incidence rate ratios were 6.9 (95% CI, 1.1 to 42.5; P less than 0.05) and 1.0 (95% CI, 0.2 to 3.9) for viridans streptococcal and Staphylococcus aureus endocarditis, respectively. The rate of first embolic events diminished over time (P less than 0.001), falling from 13 per 1000 patient-days during the first week of therapy to less than 1.2 per 1000 patient-days after completion of the second week of therapy.
CONCLUSIONS: Overall, the presence of vegetations on echocardiography was not associated with a significantly higher risk for embolus in patients with left-sided native valve infective endocarditis. The relative risk for embolic events associated with echocardiographically visualized vegetations may be microorganism-dependent, with a significantly increased risk seen only in patients with viridans streptococcal infection. The rate of embolic events declines with time after initiation of antimicrobial treatment.

Entities:  

Mesh:

Year:  1991        PMID: 2003709     DOI: 10.7326/0003-4819-114-8-635

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  50 in total

1.  Does Aspirin Prevent Emboli in Infective Endocarditis?

Authors:  James M. Steckelberg
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

Review 2.  [Infective endocarditis as cardiovascular emergency].

Authors:  B Plicht; R-A Jánosi; T Buck; R Erbel
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

3.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Embolic Risk in Subacute Bacterial Endocarditis: Determinants and Role of Transesophageal Echocardiography.

Authors:  Gilbert Habib
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

5.  Optimal timing for cardiac surgery in infective endocarditis: is earlier better?

Authors:  François Delahaye; Anne-Marie Antchouey; Guy de Gevigney
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

6.  Is there a role for antiplatelet therapy in infective endocarditis? A review of current scientific evidence.

Authors:  Nandan S Anavekar; Joseph G Murphy
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

7.  Myocardial infarction due to septic coronary artery embolism in the course of Brucella endocarditis.

Authors:  G Açar; A Ozkok; C Dönmez; A Avcı; E Alizade; M Yanartaş
Journal:  Herz       Date:  2014-03-09       Impact factor: 1.443

8.  Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.

Authors:  Cristina Teles; Andrew Smith; Sue Lang
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

9.  Infective Endocarditis in Elderly Patients.

Authors:  Vinod K. Dhawan
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

Review 10.  Fungal endocarditis--a report on seven cases and a brief review.

Authors:  H Hogevik; K Alestig
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.